DBV Technologies S.A.
Developing non-invasive skin patch immunotherapies for food allergies and immune diseases.
DBVT | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
DBV Technologies S.A. is a clinical-stage biopharmaceutical company focused on developing non-invasive therapies for food allergies and other immunological diseases. The company's core technology is the proprietary VIASKIN® patch, an investigational Epicutaneous Immunotherapy (EPIT) platform. This technology is designed to re-educate the immune system by delivering minimal amounts of antigens to intact skin, thereby avoiding direct transfer to the bloodstream. DBV's development pipeline is led by its VIASKIN® peanut patch (DBV712), which is in late-stage clinical trials. Additional programs include treatments for other food allergies, such as milk.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all DBV Technologies S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
